TheraFluor, Inc.
PrivateLast Round
Grant
Jan 1, 2025
Total Funding Raised
$1.72M
Company Overview
TheraFluor, Inc. operates in Healthcare & Life Sciences and is based in Portland, Oregon. Its latest recorded funding round was a Grant round in January 2025.
TheraFluor, Inc. is a biotechnology company that develops photosensitive dyes and instrument platforms for fluorescence-guided cancer surgery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical Imaging, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
TheraFluor, Inc. Comparables
Compare TheraFluor, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Blaze Bioscience, Inc. | 84% | |
| Antelope Surgical Solutions, Inc. | 83% | |
| Vergent Bioscience | 80% |
For institutional investors. Book with your work email.
TheraFluor, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 1, 2025 | ||||
| Grant | Jul 1, 2024 |
For institutional investors. Book with your work email.
TheraFluor, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oregon Innovation Council | Grant |
| U.S. Department of Health and Human Services | Grant |
| Oregon Business Development Department | Grant |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2025
Received grant funding from Oregon Business Development Department and Oregon Innovation Council.
- Jul 1, 2024
$275K grant from the National Science Foundation.
For institutional investors. Book with your work email.
TheraFluor, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about TheraFluor, Inc.'s valuation, stock price, and market status.
Is TheraFluor, Inc. a public or private company?
TheraFluor, Inc. is a private company.
What is the current stock price of TheraFluor, Inc.?
TheraFluor, Inc. is a private company, so its shares have no public market price. Caplight tracks TheraFluor, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is TheraFluor, Inc. worth (valuation)?
Valuation information for TheraFluor, Inc. is not publicly available.
Can I buy TheraFluor, Inc. stock?
TheraFluor, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was TheraFluor, Inc.'s last funding round?
TheraFluor, Inc.'s most recent funding round was Grant on January 1, 2025.
Who are the main investors in TheraFluor, Inc.?
Key investors in TheraFluor, Inc. include Oregon Innovation Council, U.S. Department of Health and Human Services, Oregon Business Development Department, National Science Foundation.
Will TheraFluor, Inc. IPO soon?
No public IPO plans have been announced for TheraFluor, Inc..
How can I track TheraFluor, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in TheraFluor, Inc.'s shares on secondary markets.